2009.10.06 – YM BioSciences inks deal to acquire Cytopia
YM BioSciences inks deal to acquire Cytopia
October 6, 2009 — 10:33am ET | By John Carroll
Canada’s YM BioSciences is taking over Australia’s Cytopia, combining their cancer drug programs into a single pipeline in a $14 million merger deal.
Cytopia’s lead product, CYT997, has wrapped early stage development, where it demonstrated “potent disruption of existing tumor vasculature.” It’s now in a Phase II trial.